High prevalence of blindness and ocular complications in leprosy patients

Article

Data presented in an advance on-line publication of the journal Eye has shown a high occurrence of ocular conditions in UK leprosy patients.

Data presented in an advance on-line publication of the journal Eye has shown a high occurrence of ocular conditions in UK leprosy patients.

Dr A. Malik et al., Moorfields Eye Hospital, London, UK, conducted an observational, prospective study on 126 consecutive leprosy patients. The participants were examined during their ophthalmic visits.

Of the 126 patients, 18 presented with blindness in one eye and 5 patients were blind in both eyes. The findings demonstrated that 96 patients had a visual acuity of 6/18, 28 patients had a leprosy complication that severely affects sight and 65 patients had a form of ocular complication such as lagophthalmos, severe corneal or iris disease.

The most frequent ocular complications were impaired lid closure, impaired corneal sensation, mild corneal opacity, cataract and iris atrophy. Increasing age was linked to impaired lid closure and vision less than 6/18 was linked to impaired corneal sensation.

The results revealed that one in five leprosy patients suffered from some form of ocular complication or blindness. The study advises health professionals to increase awareness on the implications of leprosy and the risk of sight-threatening ocular complications.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.